Literature DB >> 2537896

Thiamine-responsive anemia in DIDMOAD syndrome.

C Borgna-Pignatti1, P Marradi, L Pinelli, N Monetti, C Patrini.   

Abstract

Two children with the DIDMOAD syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, deafness) developed a megaloblastic and sideroblastic anemia, neutropenia, and borderline thrombocytopenia. Plasma thiamine concentration was low in one patient and normal in the other; in both children, thiamine pyrophosphate in erythrocytes and thiamine pyrophosphokinase activity were lower than the lowest values observed in control subjects. A month after institution of treatment with thiamine, the hematologic findings had returned to normal and the insulin requirements had decreased. Withdrawal of thiamine repeatedly induced relapse of the anemia and an increase in insulin requirements. We propose that an inherited abnormality of thiamine metabolism is responsible for the multisystem degenerative disorder known as DIDMOAD syndrome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537896     DOI: 10.1016/s0022-3476(89)80558-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

1.  Mitochondrial abnormalities in the DIDMOAD syndrome.

Authors:  S Bundey; K Poulton; H Whitwell; E Curtis; I A Brown; A R Fielder
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  DIDMOAD syndrome: a diagnostic as well as therapeutic dilemma.

Authors:  Muhammad Ayyub; Masood Anwar; Waqar Ali; B M Qazi
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

3.  Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion.

Authors:  A Barrientos; J Casademont; A Saiz; F Cardellach; V Volpini; A Solans; E Tolosa; A Urbano-Marquez; X Estivill; V Nunes
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

4.  Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping.

Authors:  E J Neufeld; H Mandel; T Raz; R Szargel; C N Yandava; A Stagg; S Fauré; T Barrett; N Buist; N Cohen
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

5.  Sideroblastic anaemia and primary adrenal insufficiency due to a mitochondrial respiratory chain disorder in the absence of mtDNA deletion.

Authors:  Michael J O'Grady; Ahmad A Monavari; Melanie Cotter; Nuala P Murphy
Journal:  BMJ Case Rep       Date:  2015-02-26

6.  A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome.

Authors:  A Barrientos; V Volpini; J Casademont; D Genís; J M Manzanares; I Ferrer; J Corral; F Cardellach; A Urbano-Márquez; X Estivill; V Nunes
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

7.  Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts.

Authors:  A R Stagg; J C Fleming; M A Baker; M Sakamoto; N Cohen; E J Neufeld
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

8.  Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update.

Authors:  Anke K Bergmann; Inderneel Sahai; Jill F Falcone; Judy Fleming; Adam Bagg; Caterina Borgna-Pignati; Robin Casey; Luca Fabris; Elizabeth Hexner; Lulu Mathews; Maria Leticia Ribeiro; Klaas J Wierenga; Ellis J Neufeld
Journal:  J Pediatr       Date:  2009-07-29       Impact factor: 4.406

9.  Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300).

Authors:  A Rötig; V Cormier; P Chatelain; R Francois; J M Saudubray; P Rustin; A Munnich
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

Review 10.  Mitochondrial mutation commonly associated with Leber's hereditary optic neuropathy observed in a patient with Wolfram syndrome (DIDMOAD).

Authors:  D Pilz; O W Quarrell; E W Jones
Journal:  J Med Genet       Date:  1994-04       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.